Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftriaxone Sodium I.P. 1000mg + Tazobactam Sodium I.P. 125mg
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
Mono
Price
₹186/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fritcet TZ 1.125 Injection is a potent combination antibiotic that merges the efficacy of Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. This combination is specifically designed to combat severe bacterial infections caused by beta-lactamase-producing organisms that are resistant to conventional antibiotics.
Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Tazobactam enhances its activity by neutralizing the resistance mechanisms of beta-lactamase enzymes. This dual-action makes the injection highly effective against a broad spectrum of Gram-positive and Gram-negative bacteria.
Fritcet TZ is widely prescribed for treating complicated intra-abdominal infections, skin and soft tissue infections, respiratory tract infections, urinary tract infections, and septicemia. It is also beneficial in cases where other antibiotics fail due to resistance.
Common side effects may include diarrhea, rash, and changes in liver function tests. Severe allergic reactions and Clostridium difficile-associated diarrhea have been reported.
Used to treat severe bacterial infections, including those caused by beta-lactamase-producing organisms.
Consult a healthcare professional before use. Administer only under medical supervision, particularly in cases of renal impairment or known allergies to beta-lactam antibiotics. Fritcet TZ 1.125 Injection is an important therapeutic option in combating bacterial infections. Its dual-action mechanism not only helps to control infection effectively but also addresses the challenge of antibiotic resistance. Always adhere to prescribed dosages and treatment duration to optimize the therapeutic benefits while minimizing potential adverse effects. Regular monitoring during treatment is advised to detect any side effects early, ensuring patient safety and effective management of the infection.
Store at room temperature, away from light and moisture. Ensure that the solution is protected from freezing.
Composition : Amikacin (100mg)
Composition : Amikacin (250mg)
Composition : Amikacin (500mg)
Composition : Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Azithromycin (500mg) Injection
Composition : Cefepime (1000mg) Injection
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftriaxone 1000mg + Tazobactam 125mg Injection has strong demand in the hospital, anti-infective, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics and institutional healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for moderate to severe bacterial infection management under medical supervision. Ceftriaxone 1000mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Tazobactam 125mg is a beta-lactamase inhibitor that helps enhance the effectiveness of ceftriaxone against resistant bacterial strains Commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, gynecological infections, and hospital-acquired infections Widely used in hospitals, nursing homes, and critical care settings Injectable formulation provides rapid and effective treatment for serious infections This strengthens a robust anti-infective and hospital-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftriaxone 1000mg + Tazobactam 125mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, high market acceptance, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.